Aprecia to invest $25M in Ohio plant; UN accuses Chinese drugmakers of aiding meth trade; Novartis touts efficiency gains from packaging tech;

> Aprecia Pharmaceuticals is to invest $25 million to turn a vacant building in Ohio into a production plant staffed by 150 people. More

> A United Nations official has accused corrupt elements of the Chinese pharmaceutical industry of supplying methamphetamine manufacturers with precursor chemicals. Article

> Novartis ($NVS) has explained how an investment in packaging technology allowed its plant in Cairo, India, to manufacture a wider range of products. Feature

> Nigerian regulators have destroyed counterfeit pharmaceuticals with an estimated value of $2.5 million. News

> Akorn Pharmaceuticals ($AKRX) has become the latest drugmaker to speak out against the use of midazolam for executions. The manufacturer will now only ship midazolam to a select group of wholesalers. Piece

Suggested Articles

Online pharmacy Valisure has criticized the FDA for what it deems as irrational standards in the levels of suspected carcinogens in the drug supply.

Bluebird Bio says the launch of Zynteglo, its first gene therapy, will not occur until 2020 while it tightens up its manufacturing processes.

Catalent is buying a site in Italy from Bristol-Myers Squibb that handles biologics along with old-school solid dose production.